1. Home
  2. EMBC vs PFN Comparison

EMBC vs PFN Comparison

Compare EMBC & PFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • PFN
  • Stock Information
  • Founded
  • EMBC 1924
  • PFN 2004
  • Country
  • EMBC United States
  • PFN United States
  • Employees
  • EMBC N/A
  • PFN N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • PFN Finance/Investors Services
  • Sector
  • EMBC Health Care
  • PFN Finance
  • Exchange
  • EMBC Nasdaq
  • PFN Nasdaq
  • Market Cap
  • EMBC 726.8M
  • PFN 636.0M
  • IPO Year
  • EMBC N/A
  • PFN N/A
  • Fundamental
  • Price
  • EMBC $10.61
  • PFN $7.32
  • Analyst Decision
  • EMBC Hold
  • PFN
  • Analyst Count
  • EMBC 3
  • PFN 0
  • Target Price
  • EMBC $17.00
  • PFN N/A
  • AVG Volume (30 Days)
  • EMBC 693.6K
  • PFN 331.7K
  • Earning Date
  • EMBC 05-09-2025
  • PFN 01-01-0001
  • Dividend Yield
  • EMBC 5.66%
  • PFN 11.66%
  • EPS Growth
  • EMBC N/A
  • PFN N/A
  • EPS
  • EMBC 0.89
  • PFN N/A
  • Revenue
  • EMBC $1,079,500,000.00
  • PFN N/A
  • Revenue This Year
  • EMBC N/A
  • PFN N/A
  • Revenue Next Year
  • EMBC $0.09
  • PFN N/A
  • P/E Ratio
  • EMBC $11.89
  • PFN N/A
  • Revenue Growth
  • EMBC N/A
  • PFN N/A
  • 52 Week Low
  • EMBC $10.20
  • PFN $5.94
  • 52 Week High
  • EMBC $21.48
  • PFN $7.58
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 41.36
  • PFN 59.62
  • Support Level
  • EMBC $10.20
  • PFN $7.12
  • Resistance Level
  • EMBC $11.52
  • PFN $7.35
  • Average True Range (ATR)
  • EMBC 0.64
  • PFN 0.05
  • MACD
  • EMBC -0.12
  • PFN 0.01
  • Stochastic Oscillator
  • EMBC 17.37
  • PFN 84.78

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About PFN PIMCO Income Strategy Fund II

PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.

Share on Social Networks: